Senior executive brings deep financial planning and analysis experience to leadership team. DALLAS / ACCESSWIRE / March 3, 2023 / Form Bio, the breakthrough computational life sciences platform ...

Kathleen Borthwick, the Chief Financial Officer of Passage BIO, Inc. (NASDAQ:PASG), a clinical-stage genetic medicines company currently valued at $32.66 million, recently executed a series of ...

May 29 (Reuters) - Gene therapy maker bluebird bio (BLUE.O), opens new tab on Wednesday named former Renalytix (RENX.L), opens new tab finance chief James Sterling as its CFO to oversee the ...

NEW YORK - Tourmaline Bio, Inc. (NASDAQ: TRML), a biotechnology firm focused on immune and inflammatory diseases, has promoted Ryan Robinson to the position of Chief Financial Officer and ...